Who We Are
Founded in 2023, Phagestack is at the forefront of a revolution, blending machine learning, bioinformatics, and molecular genetics to transform antibiotic development. Our expertise extends to diagnosing and manipulating bacterial ecosystems, providing pivotal data and insights not only in the battle against resistant pathogens but also in revolutionizing aquaculture, agriculture, and food production industries.
Our Expertise
Our core expertise lies in the development of machine learning-driven platforms that help design targeted antimicrobial agents. We replace the outdated "atomic bomb" model of broad-spectrum antibiotics with the precision of a "light saber"—focused solutions that strike harmful bacteria without harming surrounding ecosystems or accelerating resistance. Our technology allows developers to create treatments tailored to specific bacterial threats, reducing collateral damage and improving overall outcomes.
Why We Started On This Journey
The rise of antibiotic resistance is one of the most pressing challenges of our time. Broad-spectrum antibiotics, while powerful, often cause unintended harm to beneficial bacteria and accelerate to AMR development. We recognized that to truly protect public health and the environment, a new approach was needed—one that combines cutting-edge technology with a deep understanding of microbial ecosystems. We started Phagestack with the belief that precision is the future of antibiotics. Our journey is driven by the vision of a world where antimicrobial agents are not only highly effective but also sustainable, protecting both people and ecosystems for generations to come.
Our Mission
We are on a mission to revolutionize antibiotic development by empowering developers with data-driven, machine learning-based tools, corresponding biologics and services that precisely target bacterial threats. Our solutions help safeguard health while minimizing environmental impact, ensuring a sustainable future in the fight against antimicrobial resistance.